Company profile

Daewoong Pharmaceutical

069620 · KRX · South Korea

Public Market Listing

069620KRX

KRX primary exchange listing

Live quotes, historical charts, and market capitalization for Daewoong Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(5 total)
5Total Assets
0Approved
4Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
Showing 5 of 5 assets
Target & Modality
DWC202206 + DWC202207
Phase 3
Undisclosed / early pipelineSmall molecule
HypertensionAtherosclerotic Cardiovascular Disease
DWJ1276No recent activity
Phase 3
Angiotensin II receptor / HMG-CoA reductaseSmall molecule
Hypertension
DWP16001(Enavogliflozin)
Phase 3
SGLT2Small molecule
Type 2 DiabetesAtherosclerotic Cardiovascular Disease
OLOMAX(OLOMAX)No recent activity
Phase 3
Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule
Atherosclerotic Cardiovascular Disease
DWRX5003
Phase 1
GLP-1 receptorPeptide
Obesity

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.